RTA Laboratuvarlari Biyolojik (RTALB) — Net Asset Quality Index
RTA Laboratuvarlari Biyolojik (RTALB) has a Net Asset Quality Index of 95.4% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of TL2.23 Billion minus total liabilities of TL103.51 Million yields net assets of TL2.12 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of RTA Laboratuvarlari Biyolojik to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
RTA Laboratuvarlari Biyolojik Net Asset Quality Index Over Time (2010–2024)
This chart shows how RTA Laboratuvarlari Biyolojik's Net Asset Quality Index has evolved across 15 annual periods from 2010 to 2024. As of June 2025, the index stands at 95.4%, representing net assets of TL2.12 Billion against total assets of TL2.23 Billion TRY. Explore RTA Laboratuvarlari Biyolojik (RTALB) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for RTA Laboratuvarlari Biyolojik (2010–2024)
The table below presents the year-by-year Net Asset Quality Index for RTA Laboratuvarlari Biyolojik from 2010 to 2024, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see RTA Laboratuvarlari Biyolojik (RTALB) total market value.
| Year | Quality Index | Net Assets (TRY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 86.9% | TL1.67 Billion | TL1.92 Billion | TL252.17 Million | ▼ -2.7 pp |
| 2023 | 89.6% | TL1.62 Billion | TL1.80 Billion | TL187.77 Million | ▲ +4.1 pp |
| 2022 | 85.5% | TL632.74 Million | TL740.21 Million | TL107.47 Million | ▲ +23.3 pp |
| 2021 | 62.1% | TL343.23 Million | TL552.40 Million | TL209.17 Million | ▼ -3.3 pp |
| 2020 | 65.4% | TL167.81 Million | TL256.52 Million | TL88.72 Million | ▼ -22.9 pp |
| 2019 | 88.3% | TL86.69 Million | TL98.16 Million | TL11.47 Million | ▲ +1.9 pp |
| 2018 | 86.4% | TL57.06 Million | TL66.05 Million | TL8.99 Million | ▲ +0.4 pp |
| 2017 | 86.0% | TL54.25 Million | TL63.09 Million | TL8.84 Million | ▲ +3.5 pp |
| 2016 | 82.4% | TL50.20 Million | TL60.89 Million | TL10.69 Million | ▲ +6.6 pp |
| 2015 | 75.9% | TL46.74 Million | TL61.61 Million | TL14.88 Million | ▼ -0.9 pp |
| 2014 | 76.8% | TL37.64 Million | TL49.04 Million | TL11.40 Million | ▲ +5.8 pp |
| 2013 | 71.0% | TL20.83 Million | TL29.35 Million | TL8.52 Million | ▲ +17.2 pp |
| 2012 | 53.7% | TL10.99 Million | TL20.45 Million | TL9.46 Million | ▼ -7.6 pp |
| 2011 | 61.4% | TL10.19 Million | TL16.60 Million | TL6.41 Million | ▼ -6.6 pp |
| 2010 | 68.0% | TL11.46 Million | TL16.86 Million | TL5.39 Million | — |